Whole Body Imaging Market Size & Growth Forecast 2027–2036, By Segments (End Use, Modality, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Whole Body Imaging Market size was over USD 32.9 billion in 2026 and is likely to grow at a 5.64% CAGR between 2027 and 2036, exceeding USD 56.95 billion by 2036. The industry revenue for 2027 is estimated at USD 34.46 billion.
Get more details on this report
Request Free Sample ReportWhole Body Imaging Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 36.46% share due to advanced imaging infrastructure, widespread clinical use across oncology and neurology, and strong capacity for integrating high-value diagnostic systems into routine care.
- Asia Pacific is expanding at a 6.78% CAGR, driven by expanding diagnostic infrastructure, rising access to advanced imaging systems, and increasing demand for early and comprehensive disease detection.
Segment Momentum
- Hospitals held 48.65% share in 2026 due to high patient volumes, integrated emergency and specialty care workflows, and ability to manage complex imaging cases requiring multidisciplinary coordination.
- Computed Tomography (CT) is the fastest-growing modality due to rapid scan times, improved workflow efficiency, and suitability for high-volume diagnostic environments requiring quick clinical decision-making.
Market Expansion Drivers
- Increasing chronic disease burden driving demand for comprehensive diagnostic imaging solutions.
- Advancements in AI-enabled CT and MRI systems improving diagnostic precision and workflow efficiency.
- Growing preventive healthcare awareness accelerating adoption of full-body screening technologies.
Leading Market Participants
- Key companies in the whole body imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Mediso Ltd. (Hungary), Hologic, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 32.9 billion
- 2027 Estimated Market Size: USD 34.46 billion.
- Projected Market Size: USD 56.95 billion by 2036
- Growth Forecast: 5.64% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End Use) | Magnetic Resonance Imaging (MRI) (Modality) | Oncology (Application)
- Emerging Opportunity Segment: Diagnostic Imaging Centers (End Use) | Computed Tomography (CT) (Modality) | Metastasis Detection (Application)
Market Growth Drivers and Industry Trends
Increasing chronic disease burden driving demand for comprehensive diagnostic imaging solutions
The growing prevalence of chronic diseases is increasing the need for detailed diagnostic evaluation, and this trend will drive the whole body imaging market as healthcare systems seek comprehensive approaches to assess multiple organs and anatomical regions. Conditions such as cardiovascular disorders, cancer, metabolic diseases, and other long-term illnesses often require repeated imaging to identify abnormalities, evaluate disease progression, and support treatment planning. Whole-body imaging can provide clinicians with broader anatomical information within an integrated examination framework, helping identify findings that may extend beyond the initially suspected site of disease and supporting more informed clinical assessment.
Advancements in AI-enabled CT and MRI systems improving diagnostic precision and workflow efficiency
AI integration across CT and MRI technologies is strengthening the whole body imaging market by improving image analysis, supporting reconstruction, and streamlining workflows associated with large volumes of diagnostic information. Artificial intelligence can assist with the identification of subtle abnormalities, image enhancement, segmentation, and prioritization of potentially significant findings, allowing radiologists to manage complex examinations more efficiently. For whole-body studies, where extensive image datasets can increase interpretation demands, AI-supported tools can help reduce repetitive tasks while supporting clearer visualization and more consistent assessment of anatomical structures.
Growing preventive healthcare awareness accelerating adoption of full-body screening technologies
Greater awareness of preventive healthcare is encouraging individuals and healthcare providers to place more emphasis on detecting potential abnormalities before symptoms become advanced, creating favorable conditions for the whole body imaging market. Full-body screening technologies can provide broad assessments that help identify unexpected findings across different anatomical regions, particularly among individuals seeking proactive health evaluations. Rising interest in personalized health management and early detection is also encouraging the use of advanced imaging as part of broader preventive strategies, although screening applications remain dependent on clinical appropriateness, patient risk profiles, and healthcare provider assessment.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing chronic disease burden driving demand for comprehensive diagnostic imaging solutions | 1.80% | High | North America, Europe | High | Near Term |
| Advancements in AI-enabled CT and MRI systems improving diagnostic precision and workflow efficiency | 1.60% | Moderate | Asia Pacific, North America | High | Mid Term |
| Growing preventive healthcare awareness accelerating adoption of full-body screening technologies | 1.20% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
In the whole body imaging market, North America held the largest share of 36.46% in 2026, reflecting its sophisticated diagnostic imaging infrastructure, high utilization of advanced medical technologies, and strong emphasis on early disease detection. Healthcare providers are increasingly using comprehensive imaging approaches to support the assessment of complex conditions and improve diagnostic decision-making. Demand is further supported by investments in imaging equipment, integration of digital healthcare systems, and growing interest in preventive and personalized approaches to medical care.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region for the whole body imaging market, supported by expanding diagnostic infrastructure, improving access to advanced imaging services, and increasing healthcare expenditure. The growing burden of chronic and complex diseases is encouraging healthcare systems to strengthen diagnostic capabilities and improve access to comprehensive imaging. Hospital modernization, technological advancement, and rising awareness of early detection are also creating favorable conditions for wider adoption of whole body imaging solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Imaging SystemsGermany focuses on highly standardized whole body imaging protocols supported by advanced engineering in imaging hardware and software integration. Hospitals in Germany prioritize reproducible diagnostic accuracy and interoperability between imaging modalities in clinical decision-making workflows.
France 🇫🇷
Hospital Imaging ModernizationFrance continues upgrading whole body imaging infrastructure within public hospital systems, focusing on improved diagnostic precision and efficient patient throughput. Imaging centers in France emphasize hybrid imaging systems and coordinated radiology services.
Italy 🇮🇹
Specialized Radiology NetworksItaly’s whole body imaging market is supported by expanding specialist radiology networks and growing access to advanced diagnostic imaging technologies. Medical facilities in Italy are adopting integrated imaging platforms to enhance clinical evaluation of complex conditions.
Japan 🇯🇵
Preventive Screening FocusJapan’s whole body imaging market is strongly influenced by preventive health screening programs and high utilization of advanced imaging for early diagnosis. Medical institutions in Japan emphasize low-dose imaging techniques and patient-friendly scanning systems.
South Korea 🇰🇷
Digital Imaging IntegrationSouth Korea advances whole body imaging through rapid adoption of digital radiology platforms and AI-enhanced image reconstruction tools. Hospitals in South Korea increasingly integrate multimodal imaging systems to improve diagnostic speed and clinical workflow efficiency.
United States 🇺🇸
AI Diagnostic ExpansionThe U.S. whole body imaging market is increasingly shaped by AI-assisted interpretation and high-throughput diagnostic workflows across hospital networks. Providers in the U.S. are investing in advanced CT, PET-CT, and MRI integration to support early disease detection and streamlined radiology operations.
Segment Leadership and Growth Trends
Whole Body Imaging Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals (Largest Segment) vs Diagnostic Imaging Centers (Fastest-Growing Segment)
Hospitals accounted for 48.65% of the whole body imaging market in 2026, reflecting their broad patient base, comprehensive diagnostic infrastructure, and ability to integrate advanced imaging into multidisciplinary clinical care. Whole body imaging can support complex diagnostic evaluations across multiple specialties, making hospital-based imaging capabilities important for coordinated assessment and treatment planning. Diagnostic imaging centers are growing more rapidly as healthcare delivery increasingly emphasizes specialized, accessible, and efficient imaging services outside traditional hospital settings. The expansion of outpatient diagnostics and demand for convenient imaging access are strengthening the role of independent and specialized imaging facilities.
Modality Segment Analysis: Magnetic Resonance Imaging (MRI) (Largest Segment) vs Computed Tomography (CT) (Fastest-Growing Segment)
Magnetic resonance imaging (MRI) held the largest share of the whole body imaging market at 41.13% in 2026, supported by its ability to generate detailed soft-tissue images without ionizing radiation. MRI is particularly valuable for comprehensive examinations where high anatomical contrast and detailed visualization are essential, strengthening its use across a broad range of diagnostic applications. Computed tomography (CT) is advancing at a faster pace as improvements in imaging technology support rapid acquisition, detailed anatomical assessment, and efficient evaluation of complex conditions. Its ability to deliver comprehensive imaging within streamlined clinical workflows is increasing its relevance in whole body diagnostic examinations.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Diagnostic Imaging Centers, Others | Hospitals | Diagnostic Imaging Centers |
| Modality | Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Imaging, Others | Magnetic Resonance Imaging (MRI) | Computed Tomography (CT) |
| Application | Oncology, Trauma & Emergency Care, Metastasis Detection, Full-Body Health Screenings | Oncology | Metastasis Detection |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Key companies in the whole body imaging market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Fujifilm Holdings Corporation (Japan)
6. United Imaging Healthcare Co. Ltd. (China)
7. Shimadzu Corporation (Japan)
8. Samsung Electronics Co. Ltd. (South Korea)
9. Mediso Ltd. (Hungary)
10. Hologic Inc. (United States)
Increasing demand for early disease detection and precision diagnostics is accelerating innovation within the whole body imaging market. Companies are focusing on high-resolution imaging systems, AI-assisted diagnostics, and workflow automation to enhance clinical efficiency and diagnostic accuracy. Consolidation strategies and investments in integrated imaging platforms are further strengthening competitive positioning while supporting the development of comprehensive healthcare imaging solutions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Fujifilm Holdings Corporation (Japan) | |||||||
| United Imaging Healthcare Co. Ltd. (China) | |||||||
| Shimadzu Corporation (Japan) | |||||||
| Samsung Electronics Co. Ltd. (South Korea) | |||||||
| Mediso Ltd. (Hungary) | |||||||
| Hologic Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Prenuvo | Mar-26 | Prenuvo introduced a subscription-based model for its whole-body MRI services, priced at $1,199 annually. This strategic shift from transactional pricing to a recurring revenue structure aims to increase market penetration for elective, preventive diagnostic imaging while fostering long-term patient retention and improving accessibility to full-body screening programs. |
| United Imaging | Nov-24 | United Imaging secured Health Canada approval for its uMI Panorama digital PET/CT product family. This regulatory milestone supports the company’s geographic expansion strategy, enabling broader commercialization of its advanced nuclear medicine and diagnostic imaging platforms within the Canadian market and strengthening its global competitive footprint in whole-body imaging systems. |
| Ezra | Oct-24 | Ezra launched its “Ezra Blueprint” longevity scan, a premium elective whole-body imaging service priced at $5,995. By integrating advanced CT and MRI technologies into a specialized diagnostic package, the company is diversifying its service portfolio and expanding its market reach within the high-end preventive health segment targeting early disease risk detection. |
| Butterfly Network | Sep-24 | Butterfly Network advanced its portable imaging strategy with a handheld ultrasound probe designed for whole-body applications. By utilizing smartphone-connected, software-enabled hardware, the company is lowering barriers to entry for point-of-care diagnostics, facilitating wider clinical adoption and expanding the reach of its imaging technology across diverse, resource-constrained medical environments. |
| United Imaging | May-24 | United Imaging received FDA clearance for the uMR Jupiter 5T MRI system, the first platform to offer whole-body imaging at 5T strength. This technological milestone addresses historical limitations of ultra-high-field imaging, significantly enhancing diagnostic precision and research capabilities while reinforcing the company’s competitive positioning in advanced whole-body MRI system development. |
| Vave Health | Mar-24 | Vave Health launched a portable, wireless ultrasound probe featuring both phased and linear imaging capabilities for whole-body diagnostics. By emphasizing cost-effectiveness and workflow optimization, the company is targeting the point-of-care market to expand access to comprehensive ultrasound imaging, challenging traditional, high-capital imaging equipment providers through enhanced portability and operational flexibility. |
| GE Healthcare | Feb-24 | GE Healthcare completed the installation of its Omni Legend digital PET/CT system at Virtua Health, marking the platform's initial deployment in New Jersey. This installation highlights the ongoing commercial adoption of high-performance digital diagnostic infrastructure and the strategic integration of advanced systems into regional cardiology facilities to improve clinical workflow and diagnostic precision. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Whole Body Imaging Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Imaging Setting | Inpatient Imaging, Outpatient Imaging, Emergency & Trauma Imaging, Preventive Screening Centers |
| Reimbursement Type | Public Insurance, Private Insurance, Self-Pay, Employer-Sponsored & Other Programs |
| AI Integration Level | Conventional Imaging, AI-Assisted Image Interpretation, AI-Enabled Workflow & Decision Support, Fully Integrated AI Imaging Systems |
Whole Body Imaging Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Preventive Healthcare Screening Strategy |
|
| Imaging Workflow Optimization |
|
| AI Integration Impact Analysis |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the whole body imaging market?
How is the whole body imaging industry size expected to evolve during the forecast period?
How is the rising burden of chronic diseases driving demand for whole body imaging solutions?
How is AI integration transforming efficiency and adoption in whole body imaging systems?
Why do hospitals dominate the whole body imaging market?
Why is CT the fastest-growing imaging modality?
Why is North America the leading region in the whole body imaging market?
What is driving growth in Asia Pacific’s whole body imaging market?
Who are the leading players in the whole body imaging landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization